• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3 filed by S Nina Kjellson

    4/6/21 8:30:22 PM ET
    $PANA
    Blank Checks
    Finance
    Get the next $PANA alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    Kjellson Nina S

    (Last) (First) (Middle)
    C/O PANACEA ACQUISITION CORP. II,
    357 TEHAMA STREET, FLOOR 3

    (Street)
    SAN FRANCISCO CA 94103

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    04/06/2021
    3. Issuer Name and Ticker or Trading Symbol
    Panacea Acquisition Corp. II [ PANA ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    Remarks:
    Exhibit 24.1 -- Power of Attorney
    No securities are beneficially owned.
    Nina Kjellson, By: /s/ Scott Perlen as attorney-in-fact 04/06/2021
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $PANA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PANA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $PANA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nuvation Bio Closes Transaction with Panacea, Debuts as Publicly Traded Oncology Company

    NEW YORK, Feb. 10, 2021 /PRNewswire/ -- Nuvation Bio Inc., a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced the completion of its business combination with Panacea Acquisition Corp. (NYSE: PANA), a special purpose acquisition company (SPAC) sponsored by EcoR1 Capital. The resulting combined company will commence trading its shares on the New York Stock Exchange (NYSE) under the ticker symbol "NUVB" on February 11, 2021. The business combination was approved by Panacea's shareholders on February 9, 2021 and was previously approved by Nuvation Bio shareholders. Nuvation Bio's man

    2/10/21 4:05:00 PM ET
    $PANA
    Blank Checks
    Finance

    $PANA
    SEC Filings

    View All

    SEC Form 15-12G filed by Panacea Acquisition Corp. II

    15-12G - Panacea Acquisition Corp. II (0001828989) (Filer)

    4/28/23 1:18:26 PM ET
    $PANA
    Blank Checks
    Finance

    SEC Form 25-NSE filed by Panacea Acquisition Corp. II

    25-NSE - Panacea Acquisition Corp. II (0001828989) (Subject)

    4/18/23 4:29:11 PM ET
    $PANA
    Blank Checks
    Finance

    Panacea Acquisition Corp. II filed SEC Form 8-K: Other Events

    8-K - Panacea Acquisition Corp. II (0001828989) (Filer)

    4/10/23 4:11:09 PM ET
    $PANA
    Blank Checks
    Finance

    $PANA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Panacea Acquisition Corp. II (Amendment)

    SC 13G/A - Panacea Acquisition Corp. II (0001828989) (Subject)

    2/14/24 4:01:16 PM ET
    $PANA
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Panacea Acquisition Corp. II (Amendment)

    SC 13G/A - Panacea Acquisition Corp. II (0001828989) (Subject)

    2/14/23 8:02:36 AM ET
    $PANA
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Panacea Acquisition Corp. II (Amendment)

    SC 13G/A - Panacea Acquisition Corp. II (0001828989) (Subject)

    2/14/23 7:34:59 AM ET
    $PANA
    Blank Checks
    Finance

    $PANA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Ecor1 Panacea Holdings Ii, Llc

    4 - Panacea Acquisition Corp. II (0001828989) (Issuer)

    5/2/23 5:15:46 PM ET
    $PANA
    Blank Checks
    Finance

    SEC Form 4: EcoR1 Panacea Holdings II, LLC bought $5,450,000 worth of Class A ordinary shares (545,000 units at $10.00)

    4 - Panacea Acquisition Corp. II (0001828989) (Issuer)

    4/13/21 3:10:13 PM ET
    $PANA
    Blank Checks
    Finance

    SEC Form 3 filed by Llc Ii, Holdings Panacea Ecor1

    3 - Panacea Acquisition Corp. II (0001828989) (Issuer)

    4/6/21 8:37:38 PM ET
    $PANA
    Blank Checks
    Finance